Medicine guide
Acomplia
·
- Prescription status not stated
- Digestion, stomach, diabetes and nutrition
- Active substance
- Rimonabant
- Made by
- sanofi-aventis
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- As an adjunct to diet and exercise for the treatment of obese patients (BMI 30 kg/m2), or overweight patients (BMI 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | sanofi-aventis |
|---|---|
| Active substance | Rimonabant |
| Used in | Digestion, stomach, diabetes and nutrition |
| Classification | A08AX01 · Digestion, stomach, diabetes and nutrition |
| Authorised on | 2006-06-19 |
| Last updated by the regulator | 2009-01-30 |
| EMA product number | EMEA/H/C/000666 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.